How much research and development (R&D) cost was expensed by P&G in 2016 and 2017? What percentage of sales revenue and net income did P&G spend on R&D in 2016 and 2017? (Enter amounts in millions. Round percentages to 2 decimal places, e.g. 5.25%.)

Note: When you find the percentage of net income that P&G spent on R&D, use NET EARNINGS ATTRIBUTABLE for P&G

Consolidated Statements of Earnings 2017 2016 2015 $ 65,058 $ 65.299 $ 70.740 32,535 37.056 Amounts in millions except per share amounts; Years ended June 30 NET SALES Cost of products sold Selling general and administrative expense Venezuela deconsolidation charge OPERATING INCOME 32.909 18.949 18,568 20.616 = 2.028 13,955 13.441 579 11.049 828 Interest expense 465 171 182 149 325 440 (404) 13,257 13.369 11.012 2.725 3,063 10,194 8.287 3.342 10.027 577 10.604 5,217 15,411 (1.143 7.144 85 98 108 $ 15,326 $ 10.508 S 7,036 Interest income Other non-operating incomel (expense), net EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES Income taxes on continuing operations NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGSKLOSS) FROM DISCONTINUED OPERATIONS NET EARNINGS Less: Net earnings attributable to noncontrolling interests NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE BASIC NET EARNINGS PER COMMON SHARE (1) Earnings from continuing operations Earnings/(loss) from discontinued operations BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: (1) Earnings from continuing operations Earnings/(loss) from discontinued operations DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE $ 3.79 $ 2.92 3.59 $ 0.21 2.01 (0.42) $ 5.80 $ 3.80 $ 2.50 $ 3.49 $ 2.84 3.69 $ 1.90 0.20 (0.40) 2.44 $ 5.59 $ 3.69 $ $ 2.70 S 2.68 $ 2.59 ole to Procter & Gamble. 2017 2016 2015 $ 15,411 $ 10.604 $ 7.144 Consolidated Statements of Comprehensive Income Amounts in millions; Years ended June 30 NET EARNINGS OTHER COMPREHENSIVE INCOMENLOSS), NET OF TAX Financial statement translation Unrealized gains/(losses) on hedges (net of $(186). S5 and $739 tax, respectively) Unrealized gains (losses) on investment securities (net of S(6), 57 and 50 tax, respectively) Unrealized gains/(losses) on defined benefit retirement plans (net of $551, 5(621) and $328 tax, respectively) TOTAL OTHER COMPREHENSIVE INCOMENLOSS), NET OF TAX TOTAL COMPREHENSIVE INCOME Less: Total comprehensive income attributable to noncontrolling interests TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE (1.679) (7.220) 1 1.234 239 (306) (59) 28 24 1,401 (1,477) 844 1,275 (3,127) 5.118) 16,686 7.477 2.026 85 96 108 $ 16,601 $ 7.381 $ 1.918 Consolidated Balance Sheets 2017 2016 Amounts in millions; As of June 30 Assets CURRENT ASSETS Cash and cash equivalents S 5,569 $ 7.102 Consolidated Balance Sheets = Amounts in millions; As of June 30 2017 2016 Assets CURRENT ASSETS Cash and cash equivalents S 5,569 $ 7.102 Available-for-sale investment securities 9,568 6.248 Accounts receivable 4,594 4.373 INVENTORIES Materials and supplies 1,308 1.188 Work in process 529 563 Finished goods 2,787 2.965 Total inventories 4,624 4.716 Deferred income taxes 1.507 Prepaid expenses and other current assets 2,139 2.853 Current assets held for sale 7.185 TOTAL CURRENT ASSETS 26,494 33.782 PROPERTY, PLANT AND EQUIPMENT, NET 19,893 19,385 GOODWILL 44,699 44,350 TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET 24,187 24,527 OTHER NONCURRENT ASSETS 5.133 5,092 TOTAL ASSETS $ 120,406 $ 127,138 Liabilities and Shareholders' Equity CURRENT LIABILITIES Accounts payable $ 9,632 S 9.325 Accrued and other liabilities 7,024 7,449 Current liabilities held for sale 2.343 Debt due within one year 13,554 11.853 TOTAL CURRENT LIABILITIES 30,210 30.770 LONG-TERM DEBT 18,038 18.945 DEFERRED INCOME TAXES 8,126 9.113 OTHER NONCURRENT LIABILITIES 8.254 10.325 TOTAL LIABILITIES 64,628 89.153 SHAREHOLDERS' EQUITY Convertible Class A preferred stock, stated value $1 per share (600 shares authorized) 1,006 1.038 Non-Voting Class preferred stock, stated value $1 per share (200 shares authorized) Common stock, stated value $1 per share (10,000 shares authorized; shares issued: 2017-4.000.2, 2016 - 4.009.2) 4,009 4.009 Additional paid-in capital 63,641 83.714 Reserve for ESOP debt retirement (1,249) (1.290) Accumulated other comprehensive income (loss) (14,632) (15,907) Treasury stock, at cost (shares held: 2017 - 1.455.9.2016 - 1,341.2) (93,715) (82,176) Retained earnings 96,124 87.953 Noncontrolling interest TOTAL SHAREHOLDERS' EQUITY 55,778 57.983 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 120,406 $ 127.136 594 842 Consolidated Statements of Cash Flows 2017 2016 2015 $ 7,102 $ 6.838 $ 8,548 10.804 7,144 15,411 2,820 543 3.078 3.134 351 337 335 (815) (601) (5,490) (41) (803) (768) 2.028 2.174 450 (322) 35 349 71 110 313 (149) 1.285 928 204 (43) 162 (976) 748 184 12,753 15.435 14.608 (3,384) (3,314) (3.736) Amounts in millions; Years ended June 30 CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR OPERATING ACTIVITIES Net earnings Depreciation and amortization Loss on early extinguishment of debt Share-based compensation expense Deferred income taxes Gain on sale of assets Venezuela deconsolidation charge Goodwill and intangible asset impairment charges Change in accounts receivable Change in inventories Change in accounts payable, accrued and other liabilities Change in other operating assets and liabilities Other TOTAL OPERATING ACTIVITIES INVESTING ACTIVITIES Capital expenditures Proceeds from asset sales Cash related to deconsolidated Venezuela operations Acquisitions, net of cash acquired Purchases of short-term investments Proceeds from sales and maturities of short-term investments Pre-divestiture addition of restricted cash related to the Beauty Brands divestiture Cash transferred at closing related to the Beauty Brands divestiture Release of restricted cash upon closing of the Beauty Brands divestiture Cash transferred in Batteries divestiture Change in other investments TOTAL INVESTING ACTIVITIES FINANCING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Treasury stock purchases Treasury stock from cash infused in Batteries divestiture Impact of stock options and other TOTAL FINANCING ACTIVITIES 571 432 4.498 (908) (16) (4,843) 1,488 (874) (475) (186) (2,815) 1,354 (137) (3,647) 1.203 (998) 1,870 (143) 93 (26) (163) (5,689) (5,575) (2.890) (7,236) 2,727 3,603 (4,931) (1) (7,436) (7.287) (418) (2.580) 3.916 2.138 (2,213) (3.512) (4,004) (4.604) (1.730) 2.672 2.826 (9.213) (13,019 (5,204) 2.473 (8,568) EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (29) (381) (411) CHANGE IN CASH AND CASH EQUIVALENTS (1,533) 268 (1,712) CASH AND CASH EQUIVALENTS, END OF YEAR $ 5,569 S 7.102 $ 6.836 SUPPLEMENTAL DISCLOSURE Cash payments for interest $ 518 $ 569 $ 678 Cash payment for income taxes 3,714 3.730 4,558 Divestiture of Batteries business in exchange for shares of P&G stock(2) 4.213 Divestiture of Beauty business in exchange for shares of P&G stock and assumption of debt 11,360